Drugs for Short Bowel Syndrome Market - Global Outlook and Forecast 2023-2027

Report ID: 830114 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Drugs for Short Bowel Syndrome Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Drugs for Short Bowel Syndrome Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Drugs for Short Bowel Syndrome Overall Market Size
    2.1 Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2027
    2.2 Global Drugs for Short Bowel Syndrome Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Drugs for Short Bowel Syndrome Players in Global Market
    3.2 Top Global Drugs for Short Bowel Syndrome Companies Ranked by Revenue
    3.3 Global Drugs for Short Bowel Syndrome Revenue by Companies
    3.4 Top 3 and Top 5 Drugs for Short Bowel Syndrome Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Drugs for Short Bowel Syndrome Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Players in Global Market
        3.6.1 List of Global Tier 1 Drugs for Short Bowel Syndrome Companies
        3.6.2 List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Drugs for Short Bowel Syndrome Market Size Markets, 2021 & 2027
        4.1.2 GLP-2
        4.1.3 Growth Hormone
        4.1.4 Glutamine
        4.1.5 Other
    4.2 By Type - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
        4.2.1 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
        4.2.2 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
        4.2.3 By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2027
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
        5.2.1 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
        5.2.2 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
        5.2.3 By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2027
    6.2 By Region - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
        6.2.1 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2016-2021
        6.2.2 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2022-2027
        6.2.3 By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Drugs for Short Bowel Syndrome Revenue, 2016-2027
        6.3.2 US Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.3.3 Canada Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.3.4 Mexico Drugs for Short Bowel Syndrome Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Drugs for Short Bowel Syndrome Revenue, 2016-2027
        6.4.2 Germany Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.3 France Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.4 U.K. Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.5 Italy Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.6 Russia Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.7 Nordic Countries Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.4.8 Benelux Drugs for Short Bowel Syndrome Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Drugs for Short Bowel Syndrome Revenue, 2016-2027
        6.5.2 China Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.5.3 Japan Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.5.4 South Korea Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.5.5 Southeast Asia Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.5.6 India Drugs for Short Bowel Syndrome Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Drugs for Short Bowel Syndrome Revenue, 2016-2027
        6.6.2 Brazil Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.6.3 Argentina Drugs for Short Bowel Syndrome Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, 2016-2027
        6.7.2 Turkey Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.7.3 Israel Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.7.4 Saudi Arabia Drugs for Short Bowel Syndrome Market Size, 2016-2027
        6.7.5 UAE Drugs for Short Bowel Syndrome Market Size, 2016-2027
7 Players Profiles
    7.1 Ardelyx
        7.1.1 Ardelyx Corporate Summary
        7.1.2 Ardelyx Business Overview
        7.1.3 Ardelyx Drugs for Short Bowel Syndrome Major Product Offerings
        7.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.1.5 Ardelyx Key News
    7.2 Emmaus Life Sciences
        7.2.1 Emmaus Life Sciences Corporate Summary
        7.2.2 Emmaus Life Sciences Business Overview
        7.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Product Offerings
        7.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.2.5 Emmaus Life Sciences Key News
    7.3 GLyPharma Therapeutic
        7.3.1 GLyPharma Therapeutic Corporate Summary
        7.3.2 GLyPharma Therapeutic Business Overview
        7.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Product Offerings
        7.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.3.5 GLyPharma Therapeutic Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Drugs for Short Bowel Syndrome Major Product Offerings
        7.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.4.5 Merck Key News
    7.5 Naia Pharmaceuticals
        7.5.1 Naia Pharmaceuticals Corporate Summary
        7.5.2 Naia Pharmaceuticals Business Overview
        7.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Product Offerings
        7.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.5.5 Naia Pharmaceuticals Key News
    7.6 Nutrinia
        7.6.1 Nutrinia Corporate Summary
        7.6.2 Nutrinia Business Overview
        7.6.3 Nutrinia Drugs for Short Bowel Syndrome Major Product Offerings
        7.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.6.5 Nutrinia Key News
    7.7 OxThera
        7.7.1 OxThera Corporate Summary
        7.7.2 OxThera Business Overview
        7.7.3 OxThera Drugs for Short Bowel Syndrome Major Product Offerings
        7.4.4 OxThera Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.7.5 OxThera Key News
    7.8 Sancilio & Company
        7.8.1 Sancilio & Company Corporate Summary
        7.8.2 Sancilio & Company Business Overview
        7.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Major Product Offerings
        7.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.8.5 Sancilio & Company Key News
    7.9 Takeda
        7.9.1 Takeda Corporate Summary
        7.9.2 Takeda Business Overview
        7.9.3 Takeda Drugs for Short Bowel Syndrome Major Product Offerings
        7.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.9.5 Takeda Key News
    7.10 Zealand Pharma
        7.10.1 Zealand Pharma Corporate Summary
        7.10.2 Zealand Pharma Business Overview
        7.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Major Product Offerings
        7.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Global (2016-2021)
        7.10.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Drugs for Short Bowel Syndrome Market Opportunities & Trends in Global Market
    Table 2. Drugs for Short Bowel Syndrome Market Drivers in Global Market
    Table 3. Drugs for Short Bowel Syndrome Market Restraints in Global Market
    Table 4. Key Players of Drugs for Short Bowel Syndrome in Global Market
    Table 5. Top Drugs for Short Bowel Syndrome Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Drugs for Short Bowel Syndrome Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Drugs for Short Bowel Syndrome Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Drugs for Short Bowel Syndrome Product Type
    Table 9. List of Global Tier 1 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022-2027
    Table 30. Ardelyx Corporate Summary
    Table 31. Ardelyx Drugs for Short Bowel Syndrome Product Offerings
    Table 32. Ardelyx Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 33. Emmaus Life Sciences Corporate Summary
    Table 34. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product Offerings
    Table 35. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 36. GLyPharma Therapeutic Corporate Summary
    Table 37. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product Offerings
    Table 38. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 39. Merck Corporate Summary
    Table 40. Merck Drugs for Short Bowel Syndrome Product Offerings
    Table 41. Merck Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 42. Naia Pharmaceuticals Corporate Summary
    Table 43. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Offerings
    Table 44. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 45. Nutrinia Corporate Summary
    Table 46. Nutrinia Drugs for Short Bowel Syndrome Product Offerings
    Table 47. Nutrinia Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 48. OxThera Corporate Summary
    Table 49. OxThera Drugs for Short Bowel Syndrome Product Offerings
    Table 50. OxThera Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 51. Sancilio & Company Corporate Summary
    Table 52. Sancilio & Company Drugs for Short Bowel Syndrome Product Offerings
    Table 53. Sancilio & Company Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 54. Takeda Corporate Summary
    Table 55. Takeda Drugs for Short Bowel Syndrome Product Offerings
    Table 56. Takeda Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
    Table 57. Zealand Pharma Corporate Summary
    Table 58. Zealand Pharma Drugs for Short Bowel Syndrome Product Offerings
    Table 59. Zealand Pharma Drugs for Short Bowel Syndrome Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Drugs for Short Bowel Syndrome Segment by Type
    Figure 2. Drugs for Short Bowel Syndrome Segment by Application
    Figure 3. Global Drugs for Short Bowel Syndrome Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Drugs for Short Bowel Syndrome Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2020
    Figure 8. By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 12. US Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 16. Germany Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 17. France Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 24. China Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 28. India Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 30. Brazil Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue Market Share, 2016-2027
    Figure 33. Turkey Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2016-2027
    Figure 37. Ardelyx Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Merck Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Nutrinia Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. OxThera Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Sancilio & Company Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Takeda Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Drugs for Short Bowel Syndrome Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Short Bowel Syndrome Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Short Bowel Syndrome Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports